Search results

Page results

• Anti bribery statement - our commitment

  At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.

• Cystic fibrosis drug tested to fight inflammation in COVID-19

  Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.

• Guide to managing an IBD Flare: My Crohn’s and Ulcerative Colitis

  This page explains what to do if you think your IBD symptoms have returned and who to contact for support.

• Royal National Throat Nose and Ear Hospital, Gray's Inn Road - closure of site

  Update about our hospital on Gray's Inn Road

• Increase in delirium, rare brain inflammation and stroke linked to COVID-19

  Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.

• UCLH accelerating research delivery

  UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.

• Breathing aids developed by UCL, UCLH and F1 team delivered to 40 NHS hospitals

  Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.

• Surviving coronavirus - patients speak about the impact of the disease

  Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.

• Information for the parents of children admitted with an unexplained injury

  This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.

• UCLH welcomes its 1,000th NHS proton beam therapy patient – meet Seren

  UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.